Physician
Michael A. Fabrizio M.D., P.C.
Michael A. Fabrizio M.D., P.C. was paid $1.27M by Medicaid between Jan 2018 and Jun 2023, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoMICHAEL A. FABRIZIO M.D., P.C.
PITTSFIELD, MA 01201
PITTSFIELD, MA 01201
33aNPI1467430470assigned 01/09/2006
33bProvider typePediatrics Physician
28Total paid$1.27M
24GClaims29,855
24DCodes billed45
24AFirst – last monthJan 2018 – Jun 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#62 of 1,273
Median peer was paid$24K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,886 | $233K | |
| 2019 | 5,207 | $234K | |
| 2020 | 5,588 | $213K | |
| 2021 | 6,358 | $250K | |
| 2022 | 5,129 | $247K | |
| 2023 | 1,687 | $89K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 7,039 | 5,627 | $442K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 2,992 | 2,732 | $261K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8.4% | 1,185 | 1,160 | $107K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.6% | 1,061 | 1,054 | $97K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.0% | 776 | 769 | $76K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 3.6% | 2,260 | 2,226 | $46K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 531 | 519 | $45K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.8% | 1,185 | 1,152 | $36K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.6% | 306 | 278 | $33K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.2% | 2,736 | 2,698 | $28K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.9% | 908 | 820 | $23K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 1.5% | 2,015 | 1,988 | $19K |
33 more codes
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.0% | 994 | $13K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 181 | $9K |
| 99442 | <1% | 318 | $6K | |
| 0071A | <1% | 103 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 477 | $4K |
| 0072A | <1% | 82 | $4K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 154 | $3K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 24 | $2K |
| 90461 | <1% | 418 | $2K | |
| 96127 | <1% | 361 | $2K | |
| 87430 | <1% | 98 | $1K | |
| 85018 | <1% | 346 | $737.30 | |
| 81002 | <1% | 235 | $603.91 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 35 | $476.17 |
| 94760 | <1% | 129 | $272.38 | |
| 94664 | <1% | 16 | $162.96 | |
| 90686 | <1% | 1,182 | $18.00 | |
| 99000 | 0% | 833 | $0.00 | |
| 90698 | 0% | 78 | $0.00 | |
| 90680 | 0% | 61 | $0.00 | |
| 90620 | 0% | 40 | $0.00 | |
| 91307 | 0% | 216 | $0.00 | |
| 36416 | 0% | 17 | $0.00 | |
| 90697 | 0% | 28 | $0.00 | |
| 90744 | 0% | 14 | $0.00 | |
| 90651 | 0% | 37 | $0.00 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 12 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 16 | $0.00 |
| 90688 | 0% | 51 | $0.00 | |
| 90734 | 0% | 25 | $0.00 | |
| 90670 | 0% | 227 | $0.00 | |
| 90633 | 0% | 37 | $0.00 | |
| 90671 | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFABRIZIO, KATHLEEN (MEDICAL PRACTICE ADMINISTRATOR)